477 related articles for article (PubMed ID: 30662405)
21. An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.
Longo J; Mullen PJ; Yu R; van Leeuwen JE; Masoomian M; Woon DTS; Wang Y; Chen EX; Hamilton RJ; Sweet JM; van der Kwast TH; Fleshner NE; Penn LZ
Mol Metab; 2019 Jul; 25():119-130. PubMed ID: 31023626
[TBL] [Abstract][Full Text] [Related]
22. β-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells.
Jones S; Fernandes NV; Yeganehjoo H; Katuru R; Qu H; Yu Z; Mo H
Nutr Cancer; 2013; 65(4):600-10. PubMed ID: 23659452
[TBL] [Abstract][Full Text] [Related]
23. Contribution of Accelerated Degradation to Feedback Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Cholesterol Metabolism in the Liver.
Hwang S; Hartman IZ; Calhoun LN; Garland K; Young GA; Mitsche MA; McDonald J; Xu F; Engelking L; DeBose-Boyd RA
J Biol Chem; 2016 Jun; 291(26):13479-94. PubMed ID: 27129778
[TBL] [Abstract][Full Text] [Related]
24. The balance between induction and inhibition of mevalonate pathway regulates cancer suppression by statins: A review of molecular mechanisms.
Ahmadi Y; Ghorbanihaghjo A; Argani H
Chem Biol Interact; 2017 Aug; 273():273-285. PubMed ID: 28668359
[TBL] [Abstract][Full Text] [Related]
25. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables.
Elson CE; Yu SG
J Nutr; 1994 May; 124(5):607-14. PubMed ID: 8169651
[TBL] [Abstract][Full Text] [Related]
26. Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease.
Elson CE
J Nutr; 1995 Jun; 125(6 Suppl):1666S-1672S. PubMed ID: 7782923
[TBL] [Abstract][Full Text] [Related]
27. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
Buechler RD; Peffley DM
Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
[TBL] [Abstract][Full Text] [Related]
28. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
29. Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells.
Katuru R; Fernandes NV; Elfakhani M; Dutta D; Mills N; Hynds DL; King C; Mo H
Exp Biol Med (Maywood); 2011 May; 236(5):604-13. PubMed ID: 21540247
[TBL] [Abstract][Full Text] [Related]
30. Targeting SREBP-2-Regulated Mevalonate Metabolism for Cancer Therapy.
Xue L; Qi H; Zhang H; Ding L; Huang Q; Zhao D; Wu BJ; Li X
Front Oncol; 2020; 10():1510. PubMed ID: 32974183
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids.
Mo H; Elson CE
J Nutr; 1999 Apr; 129(4):804-13. PubMed ID: 10203554
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.
Burke YD; Stark MJ; Roach SL; Sen SE; Crowell PL
Lipids; 1997 Feb; 32(2):151-6. PubMed ID: 9075204
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of sterol synthesis by the monoterpene perillyl alcohol is unaffected by competitive 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Cerda SR; Wilkinson J; Branch SK; Broitman SA
Lipids; 1999 Jun; 34(6):605-15. PubMed ID: 10405975
[TBL] [Abstract][Full Text] [Related]
34. Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis.
Loregger A; Raaben M; Tan J; Scheij S; Moeton M; van den Berg M; Gelberg-Etel H; Stickel E; Roitelman J; Brummelkamp T; Zelcer N
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2064-2074. PubMed ID: 28882874
[TBL] [Abstract][Full Text] [Related]
35. Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase.
Fernandes NV; Yeganehjoo H; Katuru R; DeBose-Boyd RA; Morris LL; Michon R; Yu ZL; Mo H
Exp Biol Med (Maywood); 2013 Nov; 238(11):1265-74. PubMed ID: 24006306
[TBL] [Abstract][Full Text] [Related]
36. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S
Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651
[TBL] [Abstract][Full Text] [Related]
37. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
Straka MS; Panini SR
Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo.
Sharon C; Baranwal S; Patel NJ; Rodriguez-Agudo D; Pandak WM; Majumdar AP; Krystal G; Patel BB
Oncotarget; 2015 Jun; 6(17):15332-47. PubMed ID: 25895029
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.
Pandyra AA; Mullen PJ; Goard CA; Ericson E; Sharma P; Kalkat M; Yu R; Pong JT; Brown KR; Hart T; Gebbia M; Lang KS; Giaever G; Nislow C; Moffat J; Penn LZ
Oncotarget; 2015 Sep; 6(29):26909-21. PubMed ID: 26353928
[TBL] [Abstract][Full Text] [Related]
40. Statins and cancer.
Vallianou NG; Kostantinou A; Kougias M; Kazazis C
Anticancer Agents Med Chem; 2014 Jun; 14(5):706-12. PubMed ID: 24295174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
